LifeMD Inc (NASDAQ:LFMD) price on current trading day, rose 2.01% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $5.58.
A look at the stock’s price movement, the close in the last trading session was $5.47, moving within a range at $5.3805 and $5.605. The beta value (5-Year monthly) was 1.232. Turning to its 52-week performance, $12.88 and $3.99 were the 52-week high and 52-week low respectively. Overall, LFMD moved 10.28% over the past month.
LifeMD Inc’s market cap currently stands at around $246.54 million, with investors looking forward to this quarter’s earnings report slated for in January.
Analysts have a consensus estimate of 57.71M for the company’s revenue for the quarter, with a low and high estimate of 56.26M and 61M respectively. The average forecast suggests up to a 28.65% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 205.89M, representing a 34.97% jump on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that LFMD is a Hold. On the other hand, the stock is on average a 50% Sell as suggested by medium term indicators while long term indicators are putting the stock in 50% Sell category.
4 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 4 recommend LFMD as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
LFMD’s current price about -8.40% and 7.27% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 47.96, while 7-day volatility ratio is 7.90% and 9.63% in the 30-day chart. Further, LifeMD Inc (LFMD) has a beta value of 1.43, and an average true range (ATR) of 0.49. Analysts have given the company’s stock an average 52-week price target of $12, forecast between a low of $12 and high of $12. Looking at the price targets, the low is -115.05% off current price level while to achieve the yearly target high, price needs to move -115.05%. Nonetheless, investors will most likely welcome a -115.05% jump to $12 which is the analysts’ median price.
If we refocus on LifeMD Inc (NASDAQ:LFMD), historical trading data shows that trading volumes averaged 0.75 over the past 10 days and 591.69K over the past 3 months. The company’s latest data on shares outstanding shows there are 41.81 million shares.
The 21.32% of LifeMD Inc’s shares are in the hands of company insiders while institutional holders own 39.22% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 5.87 million on 2024-11-15, giving us a short ratio of 8.92. The data shows that as of 2024-11-15 short interest in LifeMD Inc (LFMD) stood at 1581.0001000000002 of shares outstanding, with shares short rising to 5.57 million registered in 2024-10-15. Current price change has pushed the stock -32.69% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the LFMD stock continues to rise going into the next quarter.
